Anti-RCHY1 Antibody

RCHY1 (RING finger and CHY zinc finger domain-containing 1), also referred to as PIRH2, operates as an E3 ubiquitin-protein ligase that targets p53 and other substrates for proteasomal degradation, positioning it at the centre of DNA damage response, cell cycle control, and apoptosis signalling. This unconjugated rabbit polyclonal reagent from Antibodies.com was raised against human RCHY1 and is validated for Western blot and immunohistochemistry workflows on human-derived samples. The 100 µl pack size supports probing multiple membranes and staining several tissue sections, while the polyclonal antibody recognises multiple epitopes on the target for robust detection. Investigators studying p53 signalling networks, oncogenic transformation, and ubiquitin-mediated proteolysis rely on this reagent to monitor endogenous RCHY1 levels across cell lines and patient tissue specimens. Aliquoting upon arrival and refrigerated storage between uses preserves antibody activity and minimises freeze-thaw cycles during longitudinal experiments.